Back
Mereo BioPharma Group Plc 10K Form
Sell
48
MREO
Mereo BioPharma Group Plc
Last Price:
$2.03
Seasonality Move:
15.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MREO News And Ratings
See the #1 stock for the next 7 days that we like better than MREO
MREO Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-7.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.29 |
| Price / Book: | 6.69 |
Profitability
| EPS (TTM): | -0.26360 |
|---|---|
| Net Income (TTM): | $-41.7M |
| Gross Margin: | $-1.1M |
| Return on Equity: | -70.81% |
| Return on Assets: | -59.61% |
Mereo BioPharma Group Plc Earnings Forecast
Key Mereo BioPharma Group Plc Financial Ratios
-
Per Share Earnings over the last 9 years have been positive in 5 years.
Mereo BioPharma Group Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MREO |
| CUSIP: | 589492 |
| Website: | mereobiopharma.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 8.71 |
| Quick Ratio: | 8.09 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MREO Technical Analysis vs Fundamental Analysis
Sell
48
Mereo BioPharma Group Plc (MREO)
is a Sell
Is Mereo BioPharma Group Plc a Buy or a Sell?
-
Mereo BioPharma Group Plc stock is rated a SellThe current Mereo BioPharma Group Plc [MREO] share price is $1.96. The Score for MREO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.